Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid Gel and Photobiomodulation in Gingivectomy
NCT07169357Phase 1Enrolling by invitation
- Sponsor
- Beirut Arab University
- Start
- Nov 2025
- Primary completion
- Feb 2026
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hyaluronic acid sodium composite gel for injection in surgical wound (3 arms), sponsored by Beirut Arab University. Primary endpoints: Landry, Turnbull and Howley Healing Index at 3 months and Visual Analogue Scale at 1 month. Started Nov 2025; status: enrolling by invitation.
02
Drugs
hyaluronic acid sodium composite gel for injection
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT07169357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07169357.